Senhwa Biosciences Competitors and Similar CompaniesClear all

Instil Bio's competitors and similar companies include Paragon Gene Therapy, Strata Oncology and Neogene Therapeutics.
Instil Bio
Instil Bio
Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies.
Paragon Gene Therapy
Paragon Gene Therapy
Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies.
Strata Oncology
Strata Oncology
Strata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics.
Neogene Therapeutics
Neogene Therapeutics
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
Founding Date
Founding Date
2008
Founding Date
1990
Founding Date
2016
Founding Date
2018
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Dallas, US HQ
Dallas, US
Locations
Baltimore, US HQ
Locations
Ann Arbor, US HQ
Locations
New York, US HQ
Amsterdam, NL
Employees
Employees
1471% decrease
Employees
59
Employees
32
Employees
191

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 90m (almost 5 years ago)
Latest funding round
$ 110m (almost 6 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 20m
Total funding raised
$ 128m
Total funding raised
$ 110m
For sources of this data, please see the company profile

View Company Profiles

Paragon Gene Therapy
HQ
Baltimore, US

Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies.

View company
Strata Oncology
HQ
Ann Arbor, US
Employees
32

Strata Oncology is a precision oncology company enabling molecular indications for cancer therapeutics.

View company
Neogene Therapeutics
HQ
New York, US
Employees
191

Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.

View company